| Price | 6.75p on 07-05-2026 at 12:35:10 |
|---|---|
| Change | 0.05p 0.75% |
| Buy | 6.80p |
| Sell | 6.70p |
| Last Trade: | Sell 22,164.00 at 6.745p |
| Day's Volume: | 1,466,787 |
| Last Close: | 6.70p |
| Open: | 6.75p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.70p - 6.75p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £72.12m |
| VWAP: | 6.742856p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 22,164 | 6.745p | Ordinary |
12:47:34 - 07-May-26 |
| Sell* | 54,324 | 6.745p | Ordinary |
12:01:31 - 07-May-26 |
| Buy* | 2,218 | 6.76p | Ordinary |
11:52:58 - 07-May-26 |
| Sell* | 58,765 | 6.72p | Ordinary |
11:28:49 - 07-May-26 |
| Sell* | 5,113 | 6.745p | Ordinary |
11:24:36 - 07-May-26 |
| Buy* | 739 | 6.76p | Ordinary |
11:12:37 - 07-May-26 |
| Sell* | 59,214 | 6.745p | Ordinary |
11:12:05 - 07-May-26 |
| Sell* | 59,214 | 6.745p | Ordinary |
11:11:42 - 07-May-26 |
| Buy* | 117 | 6.80p | SI Trade |
11:03:26 - 07-May-26 |
| Buy* | 14 | 6.80p | SI Trade |
11:03:26 - 07-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
